肥胖会伤“心”——日本晨间血压研究中心脏生物标志物分析。
Will obesity break your heart - cardiac biomarkers in the Japan Morning Surge-Home Blood Pressure study.
机构信息
Department of Internal Medicine III, Division of Cardiology, Pneumology, Angiology, and Intensive Care, University of Cologne, Cologne, Germany.
Institute of Aerospace Medicine, German Aerospace Center (DLR), Cologne, Germany.
出版信息
Hypertens Res. 2024 Mar;47(3):808-810. doi: 10.1038/s41440-023-01560-z. Epub 2024 Jan 10.
Abstract
[Image: see text]
摘要
[图片：见正文]
相似文献
1
Will obesity break your heart - cardiac biomarkers in the Japan Morning Surge-Home Blood Pressure study.肥胖会伤“心”——日本晨间血压研究中心脏生物标志物分析。
Hypertens Res. 2024 Mar;47(3):808-810. doi: 10.1038/s41440-023-01560-z. Epub 2024 Jan 10.
2
Research and Development of Information and Communication Technology-based Home Blood Pressure Monitoring from Morning to Nocturnal Hypertension.基于信息和通信技术的家庭血压监测从晨峰高血压到夜间高血压的研究与开发。
Ann Glob Health. 2016 Mar-Apr;82(2):254-73. doi: 10.1016/j.aogh.2016.02.004.
3
Direct Comparison of Home Versus Ambulatory Defined Nocturnal Hypertension for Predicting Cardiovascular Events: The Japan Morning Surge-Home Blood Pressure (J-HOP) Study.家庭血压与动态血压夜间血压对预测心血管事件的直接比较：日本清晨血压-家庭血压（J-HOP）研究。
Hypertension. 2020 Aug;76(2):554-561. doi: 10.1161/HYPERTENSIONAHA.119.14344. Epub 2020 Jun 15.
4
Seasonal Variation of Home Blood Pressure and Its Association With Target Organ Damage: The J-HOP Study (Japan Morning Surge-Home Blood Pressure).季节变化对家庭血压的影响及其与靶器官损害的关系：J-HOP 研究（日本清晨血压-家庭血压）。
Am J Hypertens. 2020 Jul 18;33(7):620-628. doi: 10.1093/ajh/hpaa027.
5
Different age-related impacts of lean and obesity on cardiovascular prognosis in Japanese patients with cardiovascular risks: The J-HOP (Japan Morning Surge-Home Blood Pressure) Study.不同年龄段的瘦体重和肥胖对日本心血管风险患者心血管预后的影响：J-HOP（日本晨间高血压-家庭血压）研究。
J Clin Hypertens (Greenwich). 2021 Feb;23(2):382-388. doi: 10.1111/jch.14161. Epub 2021 Jan 2.
6
The Combination of Non-dipper Heart Rate and High Brain Natriuretic Peptide Predicts Cardiovascular Events: The Japan Morning Surge-Home Blood Pressure (J-HOP) Study.非杓型心率与高脑利钠肽联合预测心血管事件：日本晨间血压-家庭血压（J-HOP）研究。
Am J Hypertens. 2020 Apr 29;33(5):430-438. doi: 10.1093/ajh/hpaa025.
7
[Early morning hypertension/morning blood pressure surge].[清晨高血压/血压晨峰]
Nihon Rinsho. 2014 Aug;72(8):1395-9.
8
Atrial fibrillation is associated with cardiovascular events in obese Japanese with one or more cardiovascular risk factors: The Japan Morning Surge Home Blood Pressure (J-HOP) Study.心房颤动与伴有一个或多个心血管危险因素的肥胖日本人心血管事件相关：日本晨间血压波动家庭血压（J-HOP）研究。
J Clin Hypertens (Greenwich). 2021 Mar;23(3):665-671. doi: 10.1111/jch.14170. Epub 2021 Jan 6.
9
Difference between morning and evening home blood pressure and cardiovascular events: the J-HOP Study (Japan Morning Surge-Home Blood Pressure).早晚家庭血压差异与心血管事件：J-HOP研究（日本清晨血压-家庭血压研究）
Hypertens Res. 2021 Dec;44(12):1597-1605. doi: 10.1038/s41440-021-00686-2. Epub 2021 Jul 28.
10
Day-by-day variability of blood pressure and heart rate at home as a novel predictor of prognosis: the Ohasama study.家庭中血压和心率的每日变异性作为预后的新型预测指标：大间研究
Hypertension. 2008 Dec;52(6):1045-50. doi: 10.1161/HYPERTENSIONAHA.107.104620. Epub 2008 Nov 3.
本文引用的文献
1
Predicting Major Adverse Cardiovascular Events Following Carotid Endarterectomy Using Machine Learning.使用机器学习预测颈动脉内膜切除术（CEA）后的主要不良心血管事件。
J Am Heart Assoc. 2023 Oct 17;12(20):e030508. doi: 10.1161/JAHA.123.030508. Epub 2023 Oct 7.
2
Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity.司美格鲁肽治疗射血分数保留的心力衰竭合并肥胖患者的疗效。
N Engl J Med. 2023 Sep 21;389(12):1069-1084. doi: 10.1056/NEJMoa2306963. Epub 2023 Aug 25.
3
2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA).2023ESH 动脉高血压管理指南 欧洲高血压学会动脉高血压管理工作组：得到国际高血压学会 (ISH) 和欧洲肾脏协会 (ERA) 的认可。
J Hypertens. 2023 Dec 1;41(12):1874-2071. doi: 10.1097/HJH.0000000000003480. Epub 2023 Sep 26.
4
Trends in the Prevalence of Metabolically Healthy Obesity Among US Adults, 1999-2018.美国成年人代谢健康型肥胖患病率的趋势变化，1999-2018 年。
JAMA Netw Open. 2023 Mar 1;6(3):e232145. doi: 10.1001/jamanetworkopen.2023.2145.
5
Tirzepatide Once Weekly for the Treatment of Obesity.司美格鲁肽每周一次治疗肥胖症。
N Engl J Med. 2022 Jul 21;387(3):205-216. doi: 10.1056/NEJMoa2206038. Epub 2022 Jun 4.
6
NT-ProBNP and high-sensitivity troponin T as screening tests for subclinical chronic heart failure in a general population.NT-ProBNP 和高敏肌钙蛋白 T 作为一般人群亚临床慢性心力衰竭的筛查试验。
ESC Heart Fail. 2022 Jun;9(3):1954-1962. doi: 10.1002/ehf2.13906. Epub 2022 Mar 23.
7
Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial.每周皮下司美格鲁肽与每日利拉鲁肽对无糖尿病超重或肥胖成年人体重的影响：STEP 8 随机临床试验。
JAMA. 2022 Jan 11;327(2):138-150. doi: 10.1001/jama.2021.23619.
8
Natriuretic Peptides and Risk of Type 2 Diabetes: Results From the Biomarkers for Cardiovascular Risk Assessment in Europe (BiomarCaRE) Consortium.利钠肽与 2 型糖尿病风险：来自欧洲心血管风险评估生物标志物（BiomarCaRE）联盟的结果。
Diabetes Care. 2021 Nov;44(11):2527-2535. doi: 10.2337/dc21-0811. Epub 2021 Sep 14.
9
Benefits and Risks of Bariatric Surgery in Adults: A Review.成人减肥手术的获益与风险：综述
JAMA. 2020 Sep 1;324(9):879-887. doi: 10.1001/jama.2020.12567.
10
Metabolically Healthy Obesity.代谢健康型肥胖。
Endocr Rev. 2020 May 1;41(3). doi: 10.1210/endrev/bnaa004.
Zotero 插件